nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—artery—uterine cancer	0.00256	0.0695	CbGeAlD
Zuclopenthixol—DRD5—female reproductive system—uterine cancer	0.00242	0.0657	CbGeAlD
Zuclopenthixol—DRD5—female gonad—uterine cancer	0.0022	0.0598	CbGeAlD
Zuclopenthixol—ADRA1A—epithelium—uterine cancer	0.0015	0.0408	CbGeAlD
Zuclopenthixol—HRH1—myometrium—uterine cancer	0.00148	0.0402	CbGeAlD
Zuclopenthixol—ADRA2A—myometrium—uterine cancer	0.00145	0.0395	CbGeAlD
Zuclopenthixol—ADRA1A—renal system—uterine cancer	0.00139	0.0378	CbGeAlD
Zuclopenthixol—Hypertonia—Doxorubicin—uterine cancer	0.00126	0.0013	CcSEcCtD
Zuclopenthixol—Immune system disorder—Etoposide—uterine cancer	0.00125	0.0013	CcSEcCtD
Zuclopenthixol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.0013	CcSEcCtD
Zuclopenthixol—Abnormal vision—Doxorubicin—uterine cancer	0.00125	0.0013	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00124	0.00129	CcSEcCtD
Zuclopenthixol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00128	CcSEcCtD
Zuclopenthixol—Vomiting—Progesterone—uterine cancer	0.00122	0.00127	CcSEcCtD
Zuclopenthixol—Rash—Progesterone—uterine cancer	0.00121	0.00126	CcSEcCtD
Zuclopenthixol—Dermatitis—Progesterone—uterine cancer	0.00121	0.00126	CcSEcCtD
Zuclopenthixol—Headache—Progesterone—uterine cancer	0.00121	0.00125	CcSEcCtD
Zuclopenthixol—Hot flush—Epirubicin—uterine cancer	0.0012	0.00125	CcSEcCtD
Zuclopenthixol—Increased appetite—Epirubicin—uterine cancer	0.0012	0.00124	CcSEcCtD
Zuclopenthixol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00124	CcSEcCtD
Zuclopenthixol—Menopausal symptoms—Epirubicin—uterine cancer	0.00119	0.00124	CcSEcCtD
Zuclopenthixol—Decreased appetite—Dactinomycin—uterine cancer	0.00118	0.00123	CcSEcCtD
Zuclopenthixol—Fatigue—Dactinomycin—uterine cancer	0.00117	0.00122	CcSEcCtD
Zuclopenthixol—Purpura—Epirubicin—uterine cancer	0.00117	0.00121	CcSEcCtD
Zuclopenthixol—Pain—Dactinomycin—uterine cancer	0.00116	0.00121	CcSEcCtD
Zuclopenthixol—Vascular purpura—Doxorubicin—uterine cancer	0.00116	0.00121	CcSEcCtD
Zuclopenthixol—HRH1—epithelium—uterine cancer	0.00116	0.0316	CbGeAlD
Zuclopenthixol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.0012	CcSEcCtD
Zuclopenthixol—HRH1—uterine cervix—uterine cancer	0.00115	0.0313	CbGeAlD
Zuclopenthixol—Nausea—Progesterone—uterine cancer	0.00114	0.00119	CcSEcCtD
Zuclopenthixol—ADRA2A—uterine cervix—uterine cancer	0.00113	0.0307	CbGeAlD
Zuclopenthixol—Feeling abnormal—Dactinomycin—uterine cancer	0.00112	0.00116	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Etoposide—uterine cancer	0.00112	0.00116	CcSEcCtD
Zuclopenthixol—HRH1—smooth muscle tissue—uterine cancer	0.00112	0.0304	CbGeAlD
Zuclopenthixol—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00111	0.00116	CcSEcCtD
Zuclopenthixol—Hot flush—Doxorubicin—uterine cancer	0.00111	0.00115	CcSEcCtD
Zuclopenthixol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00115	CcSEcCtD
Zuclopenthixol—Increased appetite—Doxorubicin—uterine cancer	0.00111	0.00115	CcSEcCtD
Zuclopenthixol—Migraine—Epirubicin—uterine cancer	0.00111	0.00115	CcSEcCtD
Zuclopenthixol—Menopausal symptoms—Doxorubicin—uterine cancer	0.0011	0.00114	CcSEcCtD
Zuclopenthixol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00114	CcSEcCtD
Zuclopenthixol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00114	CcSEcCtD
Zuclopenthixol—HRH1—decidua—uterine cancer	0.0011	0.0298	CbGeAlD
Zuclopenthixol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00114	CcSEcCtD
Zuclopenthixol—Malaise—Etoposide—uterine cancer	0.00109	0.00113	CcSEcCtD
Zuclopenthixol—Vertigo—Etoposide—uterine cancer	0.00108	0.00113	CcSEcCtD
Zuclopenthixol—Leukopenia—Etoposide—uterine cancer	0.00108	0.00112	CcSEcCtD
Zuclopenthixol—Purpura—Doxorubicin—uterine cancer	0.00108	0.00112	CcSEcCtD
Zuclopenthixol—ADRA2A—decidua—uterine cancer	0.00108	0.0293	CbGeAlD
Zuclopenthixol—Body temperature increased—Dactinomycin—uterine cancer	0.00108	0.00112	CcSEcCtD
Zuclopenthixol—Abdominal pain—Dactinomycin—uterine cancer	0.00108	0.00112	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Etoposide—uterine cancer	0.00106	0.0011	CcSEcCtD
Zuclopenthixol—Ataxia—Epirubicin—uterine cancer	0.00106	0.0011	CcSEcCtD
Zuclopenthixol—Convulsion—Etoposide—uterine cancer	0.00105	0.00109	CcSEcCtD
Zuclopenthixol—Hypertension—Etoposide—uterine cancer	0.00104	0.00108	CcSEcCtD
Zuclopenthixol—HRH1—endometrium—uterine cancer	0.00104	0.0283	CbGeAlD
Zuclopenthixol—Liver function test abnormal—Epirubicin—uterine cancer	0.00104	0.00108	CcSEcCtD
Zuclopenthixol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00108	CcSEcCtD
Zuclopenthixol—Migraine—Doxorubicin—uterine cancer	0.00102	0.00106	CcSEcCtD
Zuclopenthixol—ADRA2A—endometrium—uterine cancer	0.00102	0.0278	CbGeAlD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00102	0.00106	CcSEcCtD
Zuclopenthixol—Discomfort—Etoposide—uterine cancer	0.00102	0.00105	CcSEcCtD
Zuclopenthixol—Breast disorder—Epirubicin—uterine cancer	0.00102	0.00105	CcSEcCtD
Zuclopenthixol—HRH1—mammalian vulva—uterine cancer	0.00101	0.0274	CbGeAlD
Zuclopenthixol—Nasopharyngitis—Epirubicin—uterine cancer	0.00101	0.00104	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Dactinomycin—uterine cancer	0.001	0.00104	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000991	0.00103	CcSEcCtD
Zuclopenthixol—ADRA2A—mammalian vulva—uterine cancer	0.00099	0.0269	CbGeAlD
Zuclopenthixol—Anaphylactic shock—Etoposide—uterine cancer	0.000985	0.00102	CcSEcCtD
Zuclopenthixol—Ataxia—Doxorubicin—uterine cancer	0.000978	0.00102	CcSEcCtD
Zuclopenthixol—Asthenia—Dactinomycin—uterine cancer	0.000977	0.00101	CcSEcCtD
Zuclopenthixol—HTR2A—epithelium—uterine cancer	0.00097	0.0264	CbGeAlD
Zuclopenthixol—Thrombocytopenia—Etoposide—uterine cancer	0.000965	0.001	CcSEcCtD
Zuclopenthixol—Tachycardia—Etoposide—uterine cancer	0.000962	0.000999	CcSEcCtD
Zuclopenthixol—Eosinophilia—Epirubicin—uterine cancer	0.000962	0.000999	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Doxorubicin—uterine cancer	0.00096	0.000997	CcSEcCtD
Zuclopenthixol—Skin disorder—Etoposide—uterine cancer	0.000957	0.000994	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Etoposide—uterine cancer	0.000953	0.000989	CcSEcCtD
Zuclopenthixol—ADRA2A—uterus—uterine cancer	0.000943	0.0256	CbGeAlD
Zuclopenthixol—Breast disorder—Doxorubicin—uterine cancer	0.00094	0.000976	CcSEcCtD
Zuclopenthixol—Anorexia—Etoposide—uterine cancer	0.000939	0.000975	CcSEcCtD
Zuclopenthixol—HTR2A—smooth muscle tissue—uterine cancer	0.000935	0.0254	CbGeAlD
Zuclopenthixol—Diarrhoea—Dactinomycin—uterine cancer	0.000932	0.000967	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Doxorubicin—uterine cancer	0.00093	0.000966	CcSEcCtD
Zuclopenthixol—Pancytopenia—Epirubicin—uterine cancer	0.000923	0.000958	CcSEcCtD
Zuclopenthixol—Hypotension—Etoposide—uterine cancer	0.000921	0.000956	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000917	0.000952	CcSEcCtD
Zuclopenthixol—Dysuria—Epirubicin—uterine cancer	0.000908	0.000943	CcSEcCtD
Zuclopenthixol—Neutropenia—Epirubicin—uterine cancer	0.000908	0.000943	CcSEcCtD
Zuclopenthixol—HTR2A—renal system—uterine cancer	0.0009	0.0244	CbGeAlD
Zuclopenthixol—Eosinophilia—Doxorubicin—uterine cancer	0.00089	0.000924	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Epirubicin—uterine cancer	0.000887	0.000921	CcSEcCtD
Zuclopenthixol—Paraesthesia—Etoposide—uterine cancer	0.000885	0.000919	CcSEcCtD
Zuclopenthixol—Weight increased—Epirubicin—uterine cancer	0.000884	0.000918	CcSEcCtD
Zuclopenthixol—Weight decreased—Epirubicin—uterine cancer	0.000879	0.000912	CcSEcCtD
Zuclopenthixol—Dyspnoea—Etoposide—uterine cancer	0.000879	0.000912	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Epirubicin—uterine cancer	0.000876	0.00091	CcSEcCtD
Zuclopenthixol—Somnolence—Etoposide—uterine cancer	0.000876	0.00091	CcSEcCtD
Zuclopenthixol—Drowsiness—Epirubicin—uterine cancer	0.000866	0.000899	CcSEcCtD
Zuclopenthixol—Vomiting—Dactinomycin—uterine cancer	0.000866	0.000899	CcSEcCtD
Zuclopenthixol—HRH1—female reproductive system—uterine cancer	0.000863	0.0234	CbGeAlD
Zuclopenthixol—Rash—Dactinomycin—uterine cancer	0.000859	0.000891	CcSEcCtD
Zuclopenthixol—Decreased appetite—Etoposide—uterine cancer	0.000857	0.000889	CcSEcCtD
Zuclopenthixol—Pancytopenia—Doxorubicin—uterine cancer	0.000854	0.000886	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Etoposide—uterine cancer	0.000851	0.000883	CcSEcCtD
Zuclopenthixol—Fatigue—Etoposide—uterine cancer	0.00085	0.000882	CcSEcCtD
Zuclopenthixol—ADRA2A—female reproductive system—uterine cancer	0.000848	0.023	CbGeAlD
Zuclopenthixol—Jaundice—Epirubicin—uterine cancer	0.000844	0.000877	CcSEcCtD
Zuclopenthixol—Pain—Etoposide—uterine cancer	0.000843	0.000875	CcSEcCtD
Zuclopenthixol—Constipation—Etoposide—uterine cancer	0.000843	0.000875	CcSEcCtD
Zuclopenthixol—Dysuria—Doxorubicin—uterine cancer	0.000841	0.000873	CcSEcCtD
Zuclopenthixol—Neutropenia—Doxorubicin—uterine cancer	0.000841	0.000873	CcSEcCtD
Zuclopenthixol—Sweating—Epirubicin—uterine cancer	0.00083	0.000862	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00082	0.000852	CcSEcCtD
Zuclopenthixol—CYP2D6—renal system—uterine cancer	0.00082	0.0223	CbGeAlD
Zuclopenthixol—Hepatobiliary disease—Epirubicin—uterine cancer	0.000819	0.00085	CcSEcCtD
Zuclopenthixol—Weight increased—Doxorubicin—uterine cancer	0.000818	0.000849	CcSEcCtD
Zuclopenthixol—Weight decreased—Doxorubicin—uterine cancer	0.000813	0.000844	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Etoposide—uterine cancer	0.000812	0.000843	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Doxorubicin—uterine cancer	0.000811	0.000842	CcSEcCtD
Zuclopenthixol—Nausea—Dactinomycin—uterine cancer	0.000809	0.00084	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Epirubicin—uterine cancer	0.000808	0.000839	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Etoposide—uterine cancer	0.000806	0.000837	CcSEcCtD
Zuclopenthixol—Drowsiness—Doxorubicin—uterine cancer	0.000801	0.000832	CcSEcCtD
Zuclopenthixol—HRH1—female gonad—uterine cancer	0.000785	0.0213	CbGeAlD
Zuclopenthixol—Jaundice—Doxorubicin—uterine cancer	0.000781	0.000811	CcSEcCtD
Zuclopenthixol—HRH1—vagina—uterine cancer	0.000781	0.0212	CbGeAlD
Zuclopenthixol—Abdominal pain—Etoposide—uterine cancer	0.000779	0.000809	CcSEcCtD
Zuclopenthixol—Body temperature increased—Etoposide—uterine cancer	0.000779	0.000809	CcSEcCtD
Zuclopenthixol—ADRA2A—female gonad—uterine cancer	0.000772	0.0209	CbGeAlD
Zuclopenthixol—Sweating—Doxorubicin—uterine cancer	0.000768	0.000798	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Epirubicin—uterine cancer	0.000768	0.000797	CcSEcCtD
Zuclopenthixol—ADRA2A—vagina—uterine cancer	0.000767	0.0208	CbGeAlD
Zuclopenthixol—Oedema peripheral—Epirubicin—uterine cancer	0.000766	0.000795	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Epirubicin—uterine cancer	0.000764	0.000793	CcSEcCtD
Zuclopenthixol—Urethral disorder—Epirubicin—uterine cancer	0.000762	0.000791	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000758	0.000787	CcSEcCtD
Zuclopenthixol—Visual impairment—Epirubicin—uterine cancer	0.000749	0.000778	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Doxorubicin—uterine cancer	0.000748	0.000777	CcSEcCtD
Zuclopenthixol—Eye disorder—Epirubicin—uterine cancer	0.000727	0.000754	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Etoposide—uterine cancer	0.000726	0.000754	CcSEcCtD
Zuclopenthixol—Tinnitus—Epirubicin—uterine cancer	0.000725	0.000753	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Epirubicin—uterine cancer	0.000722	0.000749	CcSEcCtD
Zuclopenthixol—HTR2A—female reproductive system—uterine cancer	0.000721	0.0196	CbGeAlD
Zuclopenthixol—Urinary tract disorder—Doxorubicin—uterine cancer	0.000711	0.000738	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Doxorubicin—uterine cancer	0.000709	0.000736	CcSEcCtD
Zuclopenthixol—Asthenia—Etoposide—uterine cancer	0.000707	0.000734	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Doxorubicin—uterine cancer	0.000707	0.000734	CcSEcCtD
Zuclopenthixol—Angiopathy—Epirubicin—uterine cancer	0.000705	0.000732	CcSEcCtD
Zuclopenthixol—Urethral disorder—Doxorubicin—uterine cancer	0.000705	0.000732	CcSEcCtD
Zuclopenthixol—Immune system disorder—Epirubicin—uterine cancer	0.000702	0.000729	CcSEcCtD
Zuclopenthixol—Pruritus—Etoposide—uterine cancer	0.000697	0.000724	CcSEcCtD
Zuclopenthixol—Arrhythmia—Epirubicin—uterine cancer	0.000695	0.000721	CcSEcCtD
Zuclopenthixol—Visual impairment—Doxorubicin—uterine cancer	0.000693	0.00072	CcSEcCtD
Zuclopenthixol—Mental disorder—Epirubicin—uterine cancer	0.000681	0.000707	CcSEcCtD
Zuclopenthixol—Erythema—Epirubicin—uterine cancer	0.000677	0.000703	CcSEcCtD
Zuclopenthixol—Malnutrition—Epirubicin—uterine cancer	0.000677	0.000703	CcSEcCtD
Zuclopenthixol—Diarrhoea—Etoposide—uterine cancer	0.000674	0.0007	CcSEcCtD
Zuclopenthixol—Eye disorder—Doxorubicin—uterine cancer	0.000672	0.000698	CcSEcCtD
Zuclopenthixol—Tinnitus—Doxorubicin—uterine cancer	0.000671	0.000696	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Doxorubicin—uterine cancer	0.000668	0.000693	CcSEcCtD
Zuclopenthixol—Flatulence—Epirubicin—uterine cancer	0.000667	0.000692	CcSEcCtD
Zuclopenthixol—Tension—Epirubicin—uterine cancer	0.000664	0.00069	CcSEcCtD
Zuclopenthixol—Nervousness—Epirubicin—uterine cancer	0.000657	0.000683	CcSEcCtD
Zuclopenthixol—CYP2D6—female reproductive system—uterine cancer	0.000657	0.0178	CbGeAlD
Zuclopenthixol—Angiopathy—Doxorubicin—uterine cancer	0.000653	0.000678	CcSEcCtD
Zuclopenthixol—HTR2A—vagina—uterine cancer	0.000652	0.0177	CbGeAlD
Zuclopenthixol—Dizziness—Etoposide—uterine cancer	0.000652	0.000677	CcSEcCtD
Zuclopenthixol—Immune system disorder—Doxorubicin—uterine cancer	0.00065	0.000675	CcSEcCtD
Zuclopenthixol—Arrhythmia—Doxorubicin—uterine cancer	0.000643	0.000667	CcSEcCtD
Zuclopenthixol—Vision blurred—Epirubicin—uterine cancer	0.000638	0.000662	CcSEcCtD
Zuclopenthixol—Mental disorder—Doxorubicin—uterine cancer	0.00063	0.000654	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Epirubicin—uterine cancer	0.000628	0.000652	CcSEcCtD
Zuclopenthixol—Vomiting—Etoposide—uterine cancer	0.000627	0.000651	CcSEcCtD
Zuclopenthixol—Malnutrition—Doxorubicin—uterine cancer	0.000626	0.00065	CcSEcCtD
Zuclopenthixol—Erythema—Doxorubicin—uterine cancer	0.000626	0.00065	CcSEcCtD
Zuclopenthixol—Agitation—Epirubicin—uterine cancer	0.000622	0.000646	CcSEcCtD
Zuclopenthixol—Rash—Etoposide—uterine cancer	0.000621	0.000645	CcSEcCtD
Zuclopenthixol—Dermatitis—Etoposide—uterine cancer	0.000621	0.000645	CcSEcCtD
Zuclopenthixol—Headache—Etoposide—uterine cancer	0.000617	0.000641	CcSEcCtD
Zuclopenthixol—Flatulence—Doxorubicin—uterine cancer	0.000617	0.000641	CcSEcCtD
Zuclopenthixol—Tension—Doxorubicin—uterine cancer	0.000615	0.000638	CcSEcCtD
Zuclopenthixol—Malaise—Epirubicin—uterine cancer	0.00061	0.000634	CcSEcCtD
Zuclopenthixol—Nervousness—Doxorubicin—uterine cancer	0.000608	0.000632	CcSEcCtD
Zuclopenthixol—Vertigo—Epirubicin—uterine cancer	0.000608	0.000631	CcSEcCtD
Zuclopenthixol—Syncope—Epirubicin—uterine cancer	0.000607	0.00063	CcSEcCtD
Zuclopenthixol—Leukopenia—Epirubicin—uterine cancer	0.000606	0.000629	CcSEcCtD
Zuclopenthixol—Palpitations—Epirubicin—uterine cancer	0.000598	0.000621	CcSEcCtD
Zuclopenthixol—CYP2D6—female gonad—uterine cancer	0.000598	0.0162	CbGeAlD
Zuclopenthixol—Loss of consciousness—Epirubicin—uterine cancer	0.000595	0.000618	CcSEcCtD
Zuclopenthixol—Vision blurred—Doxorubicin—uterine cancer	0.00059	0.000613	CcSEcCtD
Zuclopenthixol—Convulsion—Epirubicin—uterine cancer	0.000586	0.000609	CcSEcCtD
Zuclopenthixol—Nausea—Etoposide—uterine cancer	0.000585	0.000608	CcSEcCtD
Zuclopenthixol—Hypertension—Epirubicin—uterine cancer	0.000584	0.000607	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Doxorubicin—uterine cancer	0.000581	0.000603	CcSEcCtD
Zuclopenthixol—Myalgia—Epirubicin—uterine cancer	0.000576	0.000598	CcSEcCtD
Zuclopenthixol—Agitation—Doxorubicin—uterine cancer	0.000576	0.000598	CcSEcCtD
Zuclopenthixol—Anxiety—Epirubicin—uterine cancer	0.000574	0.000596	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000572	0.000594	CcSEcCtD
Zuclopenthixol—Discomfort—Epirubicin—uterine cancer	0.000569	0.000591	CcSEcCtD
Zuclopenthixol—Malaise—Doxorubicin—uterine cancer	0.000565	0.000586	CcSEcCtD
Zuclopenthixol—Dry mouth—Epirubicin—uterine cancer	0.000564	0.000585	CcSEcCtD
Zuclopenthixol—Vertigo—Doxorubicin—uterine cancer	0.000563	0.000584	CcSEcCtD
Zuclopenthixol—Syncope—Doxorubicin—uterine cancer	0.000562	0.000583	CcSEcCtD
Zuclopenthixol—Leukopenia—Doxorubicin—uterine cancer	0.000561	0.000582	CcSEcCtD
Zuclopenthixol—Palpitations—Doxorubicin—uterine cancer	0.000553	0.000575	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Epirubicin—uterine cancer	0.000552	0.000574	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Doxorubicin—uterine cancer	0.00055	0.000572	CcSEcCtD
Zuclopenthixol—Shock—Epirubicin—uterine cancer	0.000543	0.000564	CcSEcCtD
Zuclopenthixol—Convulsion—Doxorubicin—uterine cancer	0.000543	0.000563	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Epirubicin—uterine cancer	0.000542	0.000562	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Epirubicin—uterine cancer	0.000541	0.000562	CcSEcCtD
Zuclopenthixol—Hypertension—Doxorubicin—uterine cancer	0.000541	0.000561	CcSEcCtD
Zuclopenthixol—Tachycardia—Epirubicin—uterine cancer	0.000539	0.00056	CcSEcCtD
Zuclopenthixol—Skin disorder—Epirubicin—uterine cancer	0.000537	0.000557	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Epirubicin—uterine cancer	0.000534	0.000554	CcSEcCtD
Zuclopenthixol—Myalgia—Doxorubicin—uterine cancer	0.000533	0.000554	CcSEcCtD
Zuclopenthixol—Anxiety—Doxorubicin—uterine cancer	0.000531	0.000552	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00053	0.00055	CcSEcCtD
Zuclopenthixol—Discomfort—Doxorubicin—uterine cancer	0.000527	0.000547	CcSEcCtD
Zuclopenthixol—Anorexia—Epirubicin—uterine cancer	0.000527	0.000547	CcSEcCtD
Zuclopenthixol—Dry mouth—Doxorubicin—uterine cancer	0.000521	0.000541	CcSEcCtD
Zuclopenthixol—Hypotension—Epirubicin—uterine cancer	0.000516	0.000536	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Doxorubicin—uterine cancer	0.000511	0.000531	CcSEcCtD
Zuclopenthixol—HRH1—lymph node—uterine cancer	0.000505	0.0137	CbGeAlD
Zuclopenthixol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000503	0.000523	CcSEcCtD
Zuclopenthixol—Shock—Doxorubicin—uterine cancer	0.000503	0.000522	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Doxorubicin—uterine cancer	0.000501	0.00052	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Doxorubicin—uterine cancer	0.0005	0.00052	CcSEcCtD
Zuclopenthixol—Insomnia—Epirubicin—uterine cancer	0.0005	0.000519	CcSEcCtD
Zuclopenthixol—Tachycardia—Doxorubicin—uterine cancer	0.000499	0.000518	CcSEcCtD
Zuclopenthixol—Skin disorder—Doxorubicin—uterine cancer	0.000496	0.000515	CcSEcCtD
Zuclopenthixol—Paraesthesia—Epirubicin—uterine cancer	0.000496	0.000515	CcSEcCtD
Zuclopenthixol—ADRA2A—lymph node—uterine cancer	0.000496	0.0135	CbGeAlD
Zuclopenthixol—Hyperhidrosis—Doxorubicin—uterine cancer	0.000494	0.000513	CcSEcCtD
Zuclopenthixol—Dyspnoea—Epirubicin—uterine cancer	0.000493	0.000511	CcSEcCtD
Zuclopenthixol—Somnolence—Epirubicin—uterine cancer	0.000491	0.00051	CcSEcCtD
Zuclopenthixol—Anorexia—Doxorubicin—uterine cancer	0.000487	0.000506	CcSEcCtD
Zuclopenthixol—Dyspepsia—Epirubicin—uterine cancer	0.000486	0.000505	CcSEcCtD
Zuclopenthixol—Decreased appetite—Epirubicin—uterine cancer	0.00048	0.000499	CcSEcCtD
Zuclopenthixol—Hypotension—Doxorubicin—uterine cancer	0.000478	0.000496	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000477	0.000495	CcSEcCtD
Zuclopenthixol—Fatigue—Epirubicin—uterine cancer	0.000476	0.000494	CcSEcCtD
Zuclopenthixol—Constipation—Epirubicin—uterine cancer	0.000472	0.00049	CcSEcCtD
Zuclopenthixol—Pain—Epirubicin—uterine cancer	0.000472	0.00049	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000466	0.000483	CcSEcCtD
Zuclopenthixol—Insomnia—Doxorubicin—uterine cancer	0.000462	0.00048	CcSEcCtD
Zuclopenthixol—Paraesthesia—Doxorubicin—uterine cancer	0.000459	0.000477	CcSEcCtD
Zuclopenthixol—Dyspnoea—Doxorubicin—uterine cancer	0.000456	0.000473	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Epirubicin—uterine cancer	0.000455	0.000473	CcSEcCtD
Zuclopenthixol—Somnolence—Doxorubicin—uterine cancer	0.000454	0.000472	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Epirubicin—uterine cancer	0.000452	0.000469	CcSEcCtD
Zuclopenthixol—Dyspepsia—Doxorubicin—uterine cancer	0.00045	0.000467	CcSEcCtD
Zuclopenthixol—Decreased appetite—Doxorubicin—uterine cancer	0.000444	0.000461	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000441	0.000458	CcSEcCtD
Zuclopenthixol—Fatigue—Doxorubicin—uterine cancer	0.000441	0.000458	CcSEcCtD
Zuclopenthixol—Constipation—Doxorubicin—uterine cancer	0.000437	0.000454	CcSEcCtD
Zuclopenthixol—Pain—Doxorubicin—uterine cancer	0.000437	0.000454	CcSEcCtD
Zuclopenthixol—Body temperature increased—Epirubicin—uterine cancer	0.000437	0.000453	CcSEcCtD
Zuclopenthixol—Abdominal pain—Epirubicin—uterine cancer	0.000437	0.000453	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Doxorubicin—uterine cancer	0.000421	0.000437	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000418	0.000434	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Epirubicin—uterine cancer	0.000407	0.000423	CcSEcCtD
Zuclopenthixol—Body temperature increased—Doxorubicin—uterine cancer	0.000404	0.00042	CcSEcCtD
Zuclopenthixol—Abdominal pain—Doxorubicin—uterine cancer	0.000404	0.00042	CcSEcCtD
Zuclopenthixol—Asthenia—Epirubicin—uterine cancer	0.000396	0.000412	CcSEcCtD
Zuclopenthixol—Pruritus—Epirubicin—uterine cancer	0.000391	0.000406	CcSEcCtD
Zuclopenthixol—Diarrhoea—Epirubicin—uterine cancer	0.000378	0.000392	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Doxorubicin—uterine cancer	0.000377	0.000391	CcSEcCtD
Zuclopenthixol—Asthenia—Doxorubicin—uterine cancer	0.000367	0.000381	CcSEcCtD
Zuclopenthixol—Dizziness—Epirubicin—uterine cancer	0.000365	0.000379	CcSEcCtD
Zuclopenthixol—Pruritus—Doxorubicin—uterine cancer	0.000362	0.000375	CcSEcCtD
Zuclopenthixol—Vomiting—Epirubicin—uterine cancer	0.000351	0.000365	CcSEcCtD
Zuclopenthixol—Diarrhoea—Doxorubicin—uterine cancer	0.00035	0.000363	CcSEcCtD
Zuclopenthixol—Rash—Epirubicin—uterine cancer	0.000348	0.000362	CcSEcCtD
Zuclopenthixol—Dermatitis—Epirubicin—uterine cancer	0.000348	0.000361	CcSEcCtD
Zuclopenthixol—Headache—Epirubicin—uterine cancer	0.000346	0.000359	CcSEcCtD
Zuclopenthixol—Dizziness—Doxorubicin—uterine cancer	0.000338	0.000351	CcSEcCtD
Zuclopenthixol—Nausea—Epirubicin—uterine cancer	0.000328	0.000341	CcSEcCtD
Zuclopenthixol—Vomiting—Doxorubicin—uterine cancer	0.000325	0.000337	CcSEcCtD
Zuclopenthixol—Rash—Doxorubicin—uterine cancer	0.000322	0.000335	CcSEcCtD
Zuclopenthixol—Dermatitis—Doxorubicin—uterine cancer	0.000322	0.000334	CcSEcCtD
Zuclopenthixol—Headache—Doxorubicin—uterine cancer	0.00032	0.000332	CcSEcCtD
Zuclopenthixol—Nausea—Doxorubicin—uterine cancer	0.000304	0.000315	CcSEcCtD
